about
Vascular Complications of Cancer ChemotherapyTherapeutic potential of endothelin receptor antagonism in kidney disease.Novel Pathophysiological Mechanisms in Hypertension.Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition.Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia.Int6/eIF3e Silencing Promotes Placenta Angiogenesis in a Rat Model of Pre-eclampsia.Exosomes released from pancreatic cancer cells enhance angiogenic activities via dynamin-dependent endocytosis in endothelial cells in vitro
P2860
Q26766269-CBE9B64F-8972-423D-989F-571D7DCB010DQ38678678-EA9418FF-4FD7-4F24-BDD8-32B395F46E40Q39040850-EA5A4601-29C2-4F7D-8497-1F0526E6D64BQ39384416-859C20AE-37CB-4183-AC53-03035BBC1572Q49887672-6FE1E801-9E9E-45A0-BB31-9161F4A1FA2EQ55223615-5775F5C9-2187-47D3-AF2F-2A6BAFC22067Q58791044-38A3B2CA-52DE-46CA-B727-7CBFF2571AA3
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Endothelin-1 and antiangiogenesis.
@en
type
label
Endothelin-1 and antiangiogenesis.
@en
prefLabel
Endothelin-1 and antiangiogenesis.
@en
P2093
P2860
P1476
Endothelin-1 and antiangiogenesis.
@en
P2093
A H Jan Danser
Anton H van den Meiracker
Stephanie Lankhorst
P2860
P304
P356
10.1152/AJPREGU.00373.2015
P577
2015-10-28T00:00:00Z